Efferon LPS demonstrates efficacy in maternal sepsis and septic shock

At the European Society of Intensive Care Medicine - ESICM LIVES 2026, Efferon CTO and Co-Founder Ivan Bessonov will present a prospective multicentre pilot study on the use of Efferon LPS in maternal sepsis.

The presentation will take place during the Systemic Inflammation and Sepsis 3 session on October 12 at 14:54, at Poster Station E.

If you are attending LIVES 2026, we invite you to join the presentation and discuss the findings!

See you in Lisbon!